Axsome Therapeutics (AXSM) Stock Price, Quote, News & History | Benzinga

Axsome Therapeutics Inc (AXSM) Stock Price, Quote, News & History

AXSMNASDAQ

Trade with Public

Trade with Public

$207.77

-0.26-0.12%

At close: Aug 21, 5:00 PM EST

$207.77

N/A

After Hours: Aug 21, 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$207.22

Close

$207.77

Volume / Avg.

734.95K / 865.24K

Day Range

$206.50 - $210.87

52 Wk Range

111.55 - 260.19

Market Cap

$10.88B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

10.09%

Days to Cover

5.11

Recent Axsome Therapeutics, Inc. News

Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results

Axsome Therapeutics (NASDAQ:AXSM) reported Q2 losses of 99 cents per share and sales of $218.4 million, missing analyst estimates. Analysts have mixed price targets for the stock.

Avi Kapoor

Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts changed outlook on top names. See complete view of all changes, upgrades, downgrades on analyst ratings page.

Avi Kapoor

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.

Avi Kapoor

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.

Avi Kapoor

Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday

Global Business Travel Group Inc (GBTG), a NYSE-listed company, saw its stock rise 57% on Monday after reporting better-than-expected financial results. Other top gainers included companies like Cabaletta Bio Inc, Celcuity Inc, and Xerox Holdings Corp.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-71.26M

Investing Cash Flow (TTM)

-700.00K

Financing Cash Flow (TTM)

88.79M

Free Cash Flow (TTM)

-71.96M

Capital Expenditure (TTM)

-700.00K

Net Change in Cash (TTM)

16.83M

Analyst Trends and Forecast

1

Apr

10

1

May

1

Jun

5

Jul

5

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$10.79B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

13.65

PB Ratio (TTM)

130.86

Earnings Yield % (TTM)

-1.80%

Earnings Yield % (FWD)

-1.07%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.59

Company Debt

Total Debt

$187.96M

LT Debt

$117.96M

LT Debt Issuance (TTM)

$280.00M

LT Debt Repayment (TTM)

-$283.09M

Total Cash

$319.85M

Debt to Equity

2.70

Issuance of Debt (TTM)

-$3.09M

Repayment of Debt (TTM)

-$283.09M

Key Statistics

Open

$207.22

Close

$207.77

Volume / Avg.

734.95K / 865.24K

Day Range

$206.50 - $210.87

52 Wk Range

111.55 - 260.19

Market Cap

$10.88B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

10.09%

Days to Cover

5.11

About

Sector

Health Care

Industry

Pharmaceuticals

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Axsome Therapeutics (AXSM) stock?

A

You can purchase shares of Axsome Therapeutics (NASDAQ:AXSM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Axsome Therapeutics (AXSM) competitors?

A

Other companies in Axsome Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Axsome Therapeutics (AXSM) stock?

A

Axsome Therapeutics has a consensus price target of $232.00.

Q

What is the current price for Axsome Therapeutics (AXSM)?

A

The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $207.77 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Axsome Therapeutics (AXSM) pay a dividend?

A

There are no upcoming dividends for Axsome Therapeutics.

Q

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

A

Axsome Therapeutics does not have any upcoming earnings scheduled.

Q

Is Axsome Therapeutics (AXSM) going to split?

A

There is no upcoming split for Axsome Therapeutics.

Q

What sector and industry does Axsome Therapeutics (AXSM) operate in?

A

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.